RNA binding protein ELAVL1-mediated USP33 stabilizes HIF1A to promote pathological proliferation, migration and angiogenesis of RECs
- PMID: 39320536
- DOI: 10.1007/s10792-024-03311-6
RNA binding protein ELAVL1-mediated USP33 stabilizes HIF1A to promote pathological proliferation, migration and angiogenesis of RECs
Abstract
Background: Dysfunction of retinal vascularization plays pathogenic roles in retinopathy of prematurity (ROP). Hypoxia-inducible factor 1 alpha (HIF1A) is activated by hypoxia and contributes to ROP progression. Herein, we clarified the mechanism underlying HIF1A activation in human retinal vascular endothelial cells (HRECs) under hypoxia.
Methods: Protein expression was assayed by immunoblot analysis. Cell migration, microtubule formation, invasion, proliferation, and viability were detected by wound-healing, tube formation, transwell, EdU, and CCK-8 assays, respectively. Bioinformatics was used to predict the deubiquitinase-HIF1A interactions and RNA binding proteins (RBPs) bound to USP33. The impact of USP33 on HIF1A deubiquitination was validated by immunoprecipitation (IP) assay. RNA stability analysis was performed with actinomycin D (Act D) treatment. The ELAVL1/USP33 interaction was assessed by RNA immunoprecipitation experiment.
Results: In hypoxia-exposed HRECs, HIF1A and USP33 protein levels were upregulated. Deficiency of HIF1A or USP33 suppressed cell migration, proliferation and microtubule formation of hypoxia-exposed HRECs. Mechanistically, USP33 deficiency led to an elevation in HIF1A ubiquitination and degradation. USP33 deficiency reduced HIF1A protein levels to suppress the proliferation and microtubule formation of hypoxia-induced HRECs. Moreover, the RBP ELAVL1 stabilized USP33 mRNA to increase USP33 protein levels. ELAVL1 decrease repressed the proliferation and microtubule formation of hypoxia-induced HRECs by reducing USP33.
Conclusion: Our study identifies a novel ELAVL1/USP33/HIF1A regulatory cascade with the ability to affect hypoxia-induced pathological proliferation, angiogenesis, and migration in HRECs.
Keywords: Deubiquitination; HIF1A; Hypoxia; Pathological angiogenesis; RBPs; Retinopathy of prematurity.
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
USP39 promotes retinal pathological angiogenesis in retinopathy of prematurity by stabilizing SIRT2 expression through deubiquitination.Int Ophthalmol. 2025 Jan 24;45(1):39. doi: 10.1007/s10792-025-03410-y. Int Ophthalmol. 2025. PMID: 39853525
-
Myeloid-Derived Vascular Endothelial Growth Factor and Hypoxia-Inducible Factor Are Dispensable for Ocular Neovascularization--Brief Report.Arterioscler Thromb Vasc Biol. 2016 Jan;36(1):19-24. doi: 10.1161/ATVBAHA.115.306681. Epub 2015 Nov 24. Arterioscler Thromb Vasc Biol. 2016. PMID: 26603154 Free PMC article.
-
The Effect and Mechanism of TRPC1, 3, and 6 on the Proliferation, Migration, and Lumen Formation of Retinal Vascular Endothelial Cells Induced by High Glucose.Ophthalmic Res. 2020;63(3):284-294. doi: 10.1159/000503724. Epub 2020 Feb 25. Ophthalmic Res. 2020. PMID: 32097940
-
Endothelial deletion of phospholipase D2 reduces hypoxic response and pathological angiogenesis.Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1697-703. doi: 10.1161/ATVBAHA.114.303416. Epub 2014 Jun 19. Arterioscler Thromb Vasc Biol. 2014. PMID: 24947526
-
CircPDE4B inhibits retinal pathological angiogenesis via promoting degradation of HIF-1α though targeting miR-181c.IUBMB Life. 2020 Sep;72(9):1920-1929. doi: 10.1002/iub.2307. Epub 2020 Jun 25. IUBMB Life. 2020. PMID: 32584521
References
-
- Amadio M, Bucolo C, Leggio GM, Drago F, Govoni S, Pascale A (2010) The PKCbeta/HuR/VEGF pathway in diabetic retinopathy. Biochem Pharmacol 80:1230–1237. https://doi.org/10.1016/j.bcp.2010.06.033 - DOI - PubMed
-
- Chiang MF, Quinn GE, Fielder AR, Ostmo SR, Paul Chan RV, Berrocal A, Binenbaum G, Blair M, Peter Campbell J, Capone A, Jr., Chen Y, Dai S, Ells A, Fleck BW, Good WV, Elizabeth Hartnett M, Holmstrom G, Kusaka S, Kychenthal A, Lepore D, Lorenz B, Martinez-Castellanos MA, Özdek Ş, Ademola-Popoola D, Reynolds JD, Shah PK, Shapiro M, Stahl A, Toth C, Vinekar A, Visser L, Wallace DK, Wu WC, Zhao P, Zin A (2021) International classification of retinopathy of prematurity, Third Edition. Ophthalmology 128:e51-e68. https://doi.org/10.1016/j.ophtha.2021.05.031
-
- Dai C, Webster KA, Bhatt A, Tian H, Su G, Li W (2021) Concurrent physiological and pathological angiogenesis in retinopathy of prematurity and emerging therapies. Int J Mol Sci. https://doi.org/10.3390/ijms22094809 - DOI - PubMed - PMC
-
- Deng Y, Li S, Li S, Yu C, Huang D, Chen H, Yin X (2020) CircPDE4B inhibits retinal pathological angiogenesis via promoting degradation of HIF-1α though targeting miR-181c. IUBMB Life 72:1920–1929. https://doi.org/10.1002/iub.2307 - DOI - PubMed
-
- Fevereiro-Martins M, Marques-Neves C, Guimarães H, Bicho M (2023) Retinopathy of prematurity: a review of pathophysiology and signaling pathways. Surv Ophthalmol 68:175–210. https://doi.org/10.1016/j.survophthal.2022.11.007 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous